Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Am J Physiol Lung Cell Mol Physiol ; 316(1): L94-L104, 2019 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-30358437

RESUMO

Nicotine is a highly addictive principal component of both tobacco and electronic cigarette that is readily absorbed in blood. Nicotine-containing electronic cigarettes are promoted as a safe alternative to cigarette smoking. However, the isolated effects of inhaled nicotine are largely unknown. Here we report a novel rat model of aerosolized nicotine with a particle size (~1 µm) in the respirable diameter range. Acute nicotine inhalation caused increased pulmonary edema and lung injury as measured by enhanced bronchoalveolar lavage fluid protein, IgM, lung wet-to-dry weight ratio, and high-mobility group box 1 (HMGB1) protein and decreased lung E-cadherin protein. Immunohistochemical analysis revealed congested blood vessels and increased neutrophil infiltration. Lung myeloperoxidase mRNA and protein increased in the nicotine-exposed rats. Complete blood counts also showed an increase in neutrophils, white blood cells, eosinophils, and basophils. Arterial blood gas measurements showed an increase in lactate. Lungs of nicotine-inhaling animals revealed increased mRNA levels of IL-1A and CXCL1. There was also an increase in IL-1α protein. In in vitro air-liquid interface cultures of airway epithelial cells, there was a dose dependent increase in HMGB1 release with nicotine treatment. Air-liquid cultures exposed to nicotine also resulted in a dose-dependent loss of barrier as measured by transepithelial electrical resistance and a decrease in E-cadherin expression. Nicotine also caused a dose-dependent increase in epithelial cell death and an increase in caspase-3/7 activities. These results show that the nicotine content of electronic cigarettes may have adverse pulmonary and systemic effects.


Assuntos
Barreira Alveolocapilar , Nicotina/efeitos adversos , Vaping , Aerossóis , Animais , Barreira Alveolocapilar/lesões , Barreira Alveolocapilar/metabolismo , Barreira Alveolocapilar/patologia , Caspase 3/metabolismo , Caspase 7/metabolismo , Quimiocina CXCL1/sangue , Proteína HMGB1/metabolismo , Imunoglobulina M/sangue , Interleucina-1alfa/sangue , Contagem de Leucócitos , Masculino , Infiltração de Neutrófilos/efeitos dos fármacos , Neutrófilos/metabolismo , Neutrófilos/patologia , Nicotina/farmacologia , Tamanho da Partícula , Edema Pulmonar/sangue , Edema Pulmonar/induzido quimicamente , Edema Pulmonar/patologia , Ratos , Ratos Sprague-Dawley , Vaping/efeitos adversos , Vaping/sangue , Vaping/patologia
2.
Rev Bras Cir Cardiovasc ; 29(2): 186-91, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25140468

RESUMO

OBJECTIVE: Congenital heart diseases are observed in 5 to 8 of every 1000 live births. The presence of a valuable biomarker during the surgical periods may aid the clinician in a more accurate prognosis during treatment. METHODS: For this reason, surfactant protein B plasma levels may help to evaluate patients with cardiac problems diminishing the alveolocapillary membrane stability. In this study, plasma levels of this biomarker were measured in the preoperative and postoperative periods. This study was conducted to detect the differences between pulmonary hypertensive and normotensive patients. The differences before and after cardiopulmonary bypass were examined. RESULTS: The differences in cardiopulmonary bypass time, cross-clamp time , inotropic support dose, and duration of intensive care of patients with and without pulmonary hypertensive were found to be statistically significant (P<0.05). The results revealed that this pathophysiological state was related to other variables that were studied. We believe that the differences in preoperative and postoperative SPB levels could be attributed to alveolocapillary membrane damage and alveolar surfactant dysfunction. We found that this pathophysiological condition was significantly associated with postoperative parameters. CONCLUSION: The findings of the current study showed that surfactant protein B was present in the blood of patients with a congenital heart disease during the preoperative period. Long by-pass times may exert damage to the alveolocapillary membrane in patients with pulmonary hypertension and preoperative heart failure, and it is recommended to keep the option of surfactant therapy in mind during the postoperative course at the intensive care unit before preparing the patients for extubation.


Assuntos
Ponte Cardiopulmonar/efeitos adversos , Cardiopatias Congênitas/sangue , Cardiopatias Congênitas/cirurgia , Período Pós-Operatório , Proteína B Associada a Surfactante Pulmonar/sangue , Biomarcadores/sangue , Barreira Alveolocapilar/lesões , Ensaio de Imunoadsorção Enzimática , Humanos , Hipertensão Pulmonar , Período Pré-Operatório , Prognóstico , Proteína B Associada a Surfactante Pulmonar/uso terapêutico , Valores de Referência , Estatísticas não Paramétricas , Fatores de Tempo , Resultado do Tratamento
3.
Rev. bras. cir. cardiovasc ; 29(2): 186-191, Apr-Jun/2014. tab
Artigo em Inglês | LILACS | ID: lil-719422

RESUMO

Objective: Congenital heart diseases are observed in 5 to 8 of every 1000 live births. The presence of a valuable biomarker during the surgical periods may aid the clinician in a more accurate prognosis during treatment. Methods: For this reason, surfactant protein B plasma levels may help to evaluate patients with cardiac problems diminishing the alveolocapillary membrane stability. In this study, plasma levels of this biomarker were measured in the preoperative and postoperative periods. This study was conducted to detect the differences between pulmonary hypertensive and normotensive patients. The differences before and after cardiopulmonary bypass were examined. Results: The differences in cardiopulmonary bypass time, cross-clamp time , inotropic support dose, and duration of intensive care of patients with and without pulmonary hypertensive were found to be statistically significant (P<0.05). The results revealed that this pathophysiological state was related to other variables that were studied. We believe that the differences in preoperative and postoperative SPB levels could be attributed to alveolocapillary membrane damage and alveolar surfactant dysfunction. We found that this pathophysiological condition was significantly associated with postoperative parameters. Conclusion: The findings of the current study showed that surfactant protein B was present in the blood of patients with a congenital heart disease during the preoperative period. Long by-pass times may exert damage to the alveolocapillary membrane in patients with pulmonary hypertension and preoperative heart failure, and it is recommended to keep the option of surfactant therapy in mind during the postoperative course at the intensive care unit before preparing the patients for extubation. .


Objetivo: As cardiopatias congênitas são observadas em 5 a 8 em cada 1.000 nascidos vivos. A presença de um biomarcador importante durante os períodos cirúrgicos pode auxiliar o clínico a um prognóstico mais preciso durante o tratamento. Métodos: Por esta razão, os níveis plasmáticos de proteína B do surfactante podem ajudar a avaliar os pacientes com problemas cardíacos, diminuindo a estabilidade da membrana alvéolo-capilar. Neste estudo, os níveis plasmáticos deste biomarcador foram medidos nos períodos pré-operatório e pós-operatório. Este estudo foi realizado para detectar as diferenças entre pacientes hipertensos e normotensos em nível pulmonar. As diferenças antes e depois da circulação extracorpórea foram examinadas. Resultados: As diferenças no tempo de circulação extracorpórea, tempo de pinçamento, a dose de drogas vasoativas, e a duração da terapia intensiva de pacientes com e sem hipertensão pulmonar foram estatisticamente significativas (P<0,05). Os resultados revelaram que este estado fisiopatológico foi relacionado a outras variáveis que foram estudadas. Acreditamos que as diferenças nos níveis de SPB pré-operatório e pós-operatório pode ser atribuída a danos na membrana alvéolo-capilar e disfunção do surfactante alveolar. Descobrimos que esta condição fisiopatológica foi significativamente associada com parâmetros pós-operatórios. Conclusão: Os resultados do estudo mostraram que a proteína B surfactante estava presente no sangue de pacientes com doença cardíaca congênita no pré-operatório. Longos tempos de circulação extracorpórea podem exercer danos na membrana alvéolo-capilar em pacientes com ...


Assuntos
Humanos , Ponte Cardiopulmonar/efeitos adversos , Cardiopatias Congênitas/sangue , Cardiopatias Congênitas/cirurgia , Período Pós-Operatório , Proteína B Associada a Surfactante Pulmonar/sangue , Biomarcadores/sangue , Barreira Alveolocapilar/lesões , Ensaio de Imunoadsorção Enzimática , Hipertensão Pulmonar , Período Pré-Operatório , Prognóstico , Proteína B Associada a Surfactante Pulmonar/uso terapêutico , Valores de Referência , Estatísticas não Paramétricas , Fatores de Tempo , Resultado do Tratamento
4.
Thorac Cardiovasc Surg ; 55(7): 450-3, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18027471

RESUMO

BACKGROUND: The occurrence of complications after major pulmonary resection is known to be related to various factors. However, peri-surgical injuries to the ipsilateral non-diseased lobes(s) occurring during resection have never been mentioned in the literature. This study aimed to verify the injury in cases after lobectomy and wedge resection. METHODS: Data from eighteen patients who underwent lobectomy or wedge resection for malignant tumor between January 2003 and January 2004 were collected. All patients had pre- and postoperative examinations of alveolar-capillary membrane (A/C) permeability using 99m TC-DPTA radioaerosol. RESULTS: Ten lobectomies and eight wedge resection were performed. Using the paired t-test with each patient's pre-operative A/C permeability as his own control data, the postoperative A/C permeability of the ipsilateral non-diseased lobe(s) was found to be significantly increased. The degree of increase in the lobectomy group was the same as that in the wedge resection group. However, no significant change was found on the contralateral side in both groups. CONCLUSION: The degree of increase of permeability was the same in both groups, indicating that the effects of stretch on the surviving lung are not a contributing factor to the change in A/C permeability. The mechanical injuries during the pulmonary surgical procedure alter the permeability, which could be a possible factor causing postoperative pulmonary complications.


Assuntos
Barreira Alveolocapilar/lesões , Permeabilidade Capilar , Pneumopatias/etiologia , Lesão Pulmonar , Neoplasias Pulmonares/cirurgia , Pneumonectomia/efeitos adversos , Administração por Inalação , Adulto , Aerossóis , Idoso , Barreira Alveolocapilar/diagnóstico por imagem , Barreira Alveolocapilar/metabolismo , Feminino , Humanos , Pulmão/diagnóstico por imagem , Pulmão/metabolismo , Pulmão/cirurgia , Pneumopatias/diagnóstico por imagem , Pneumopatias/metabolismo , Neoplasias Pulmonares/diagnóstico por imagem , Neoplasias Pulmonares/metabolismo , Masculino , Pessoa de Meia-Idade , Pneumonectomia/métodos , Cintilografia , Compostos Radiofarmacêuticos/administração & dosagem , Estresse Mecânico , Pentetato de Tecnécio Tc 99m/administração & dosagem , Resultado do Tratamento
5.
Scand Cardiovasc J ; 37(4): 216-21, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12944210

RESUMO

OBJECTIVE: In spite of the advances in technology and surgical techniques, cardiac surgical operations with the use of cardiopulmonary bypass (CPB) are still associated with pulmonary morbidity and mortality. The purpose of this study is to morphologically analyze the structure of air-blood barriers in patients who underwent coronary artery bypass grafting (CABG) with use of CPB. DESIGN: The investigation involved 50 patients aged 48-75 who underwent CABG with the use of extracorporeal circulation (ECC). Lung tissue specimens, which were taken before and after CPB, were observed with light and electron microscopy. RESULTS: Both light and electron microscopic observations of pre-pump specimens did not show any pathological changes within the terminal part of the respiratory system. Morphological observations of tissue samples obtained after CPB revealed features of air-blood barrier injury and presence of surfactant within the alveolar capillaries. CONCLUSION: Whatever the mechanism of the aforementioned changes one should be aware that the presented results indicate that air-blood barriers become leaky after CABG is performed with the aid of ECC.


Assuntos
Barreira Alveolocapilar/lesões , Ponte Cardiopulmonar/efeitos adversos , Ponte de Artéria Coronária/efeitos adversos , Idoso , Biópsia , Barreira Alveolocapilar/citologia , Barreira Alveolocapilar/patologia , Capilares/citologia , Capilares/lesões , Capilares/metabolismo , Endotélio Vascular/citologia , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Eritrócitos/citologia , Eritrócitos/metabolismo , Feminino , Humanos , Masculino , Microscopia Eletrônica de Varredura , Microscopia de Polarização , Pessoa de Meia-Idade , Neutrófilos/citologia , Neutrófilos/metabolismo , Índice de Gravidade de Doença , Estatística como Assunto , Falha de Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA